Advances in drug delivery of oral hypoglycemic agents

Current Science

Volumn 83, Issue 12, 2002, Pages 1539-1543

  Kadhe, G ^a   Arasan, R E ^a  

^a USV Limited   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042697522     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lebovitz, H. E., in Diabetes: Clinical Science in Practice (eds Leslie, R. D. and Robbins, D. C.), Cambridge University Press, New York, 1995, pp. 450-464.
2. Rockville, M. D., Diabetes 1996 Vital Statistics, American Diabetes Association, USA, 1996.
3. Harris, M. I. et al., Diabetes in America, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 1995, NIH Publication No. 95-1468, 2nd edn.
4. Banerji, M. A. and Lebovitz, H. E., Diabetes, 1989, 38, 784-792.
5. Eriksson, J. et al., New Engl. J. Med., 1989, 321, 337-343.
6. Lebovitz, H. E., in Diabetes: Clinical Science in Practice (eds Leslie, R. D. and Robbins, D. C.), Cambridge University Press, New York, 1995, pp. 450-464.
7. Consensus statement (ADA), Diab. Care, 1995, 18, 1510-1518.
8. Schatz, H., Exp. Clin. Endocrinol. Diab., 1999, 107, S144-S148.
9. Martens, F. M., Visseren, F. L., Lemay, J., de Koning, E. J. and Rabelink, T. J., Drugs, 2002, 62, 1463-1480.
10. Acarbose: The Complete Drug Reference Martindale, 32nd edition, The Pharmaceutical Press, UK, 1999, pp. 317-318.
11. Brogden, R. N. et al., Drugs, 1979, 18, 329.
12. Simonson, D. C. et al., Diab. Care, 1997, 20, 597-605.
13. Data on file, USV Ltd, Mumbai.
14. Cusi, K. and Defronzo, R. A., Diab. Rev., 1998, 6, 89-131.
15. Tucker, G. et al., Br. J. Clin. Pharmacol., 1981, 21, 235-246.
16. Pentikainin, P., Neuvonen, P. and Penttila, A., Eur. J. Clin. Pharmacol., 1979, 16, 195-202.
17. Noel, M., Res. Clin. Forum 1, 1979, 35-45.
18. Garber, A. et al., Am. J. Med., 1997, 102, 491-497.
19. Guidelines for Industry: Food Effects Bioavailability and Fed Bioequivalence Studies - Study Design, Data Analysis and Labeling, US Department of Health and Human Services, October 2001 BP.
20. Good Clinical Practice. Guidelines for Clinical Trials on Pharmaceutical Products in India, Central Drugs Standard Control Organization, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, New Delhi.